Martin Shkreli is back. At least, a musical version of him is back.
Last summer, we had the brief debut of the musical satire, "Martin Shkreli's Game: How Bill Murray Joined the Wu-Tang Clan," by Lauren Gungrum and Joel Esher and starring Patrick Swailes Caldwell as Martin Shkreli.
Now, just in time for Martin Shkreli’s criminal trial for securities fraud, the play is back and this time with a new name – “PharmaBro: An American Douchical”.
According to the show’s website
, it “is a story about corporate greed, the American Dream gone wrong, and what happens when you try to f*** with a certain hip-hop group and their pal Bill Murray.”
Reviews from last year’s performance are cryptic at best. Yahoo Music wrote “the musical heist you never knew you wanted but would DEFINITELY go see” and New York Theatre Review said it is a “wacky and often wonderful new musical”.
The play will run May 11th - June 18th, 2017 at the Players Theatre in New York, NY. Shkreli’s trial begins June 26th
About Martin Shkreli
Shkreli has been involved in multiple controversies in the past few years, including his ousting as CEO of the orphan drug company Retrophin, his 55-fold price hiking of the low cost drug Daraprim as CEO of Turing Pharmaceuticals and more recently, his takeover of the orphan drug company KaloBios that sent its stock prices soaring – until they crumbled in wake of Shkreli’s legal issues.
Retrophin, the company Shkreli once ran as CEO, sued Shkreli for $65 million, claiming he had used his control over Retrophin to enrich himself and pay off debts related to MSMB management where Shkreli was a hedge fund manager. Mr Shkreli is being charge with multiple counts of fraud from his days as a hedge fund manager and CEO of Retrophin. His trial is set for the end of June. Shkreli is currently out on bail and regularly entertains his followers on youtube
Outside of running biotech companies and hedge funds, Martin regularly flaunts his power and money. To give an example, he bought the only copy of Wu-Tang Clan’s album “Once Upon a Time in Shaolin” for $2 million. That purchase ended up being the main plot point of the new musical. You have been warned.